S31
Olga Obrezanova
Lonza Biologics plc
Applied Protein Services
The Portway
Granta Park
Cambridge CB21 6GS, UK
Papers:
S31
Developability and pre-process risk assessment in biopharmaceutical development: a critical aspect in QbD implementation